The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp748
NON-INVASIVE TESTING FOR DETECTION OF GI CANCERS: WHERE ARE WE NOW AND WHERE WILL THE NIH VANGUARD STUDY LEAD US?
Date
May 20, 2024
Explore related products in the following collection:
Gastric cancer (GC) incidence is declining and too low in the US to recommend general population screening. However, the risk of developing GC in the US is substantially higher in ethnic minorities, potentially warranting screening in specific population subgroups. While _H…
BACKGROUND: Evidence of gastric cancer (GC) screening’s impact on GC incidence remains limited, hindering the development of health policies for screening programs. We aimed to assess the population impact of organized GC screening programs on GC incidence in Seoul, South Korea…
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
BACKGROUND: Screening decreases CRC incidence and mortality, but many persons remain unscreened. Offering FIT to those who decline colonoscopy improves screening participation. Offering colonoscopy in a FIT-based program has not been studied systematically…